Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62023TB0005

Case T-5/23: Order of the General Court of 13 January 2025 – Illumina v Commission (Competition – Concentrations – Pharmaceutical industry market – Genetic sequencing systems – Acquisition by Illumina of sole control over Grail – Decision imposing interim measures pursuant to Article 8(5)(c) of Regulation (EC) No 139/2004 – Withdrawal of the contested act – Disappearance of the subject matter of the action – No need to adjudicate)

OJ C, C/2025/1884, 7.4.2025, ELI: http://data.europa.eu/eli/C/2025/1884/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2025/1884/oj

European flag

Official Journal
of the European Union

EN

C series


C/2025/1884

7.4.2025

Order of the General Court of 13 January 2025 – Illumina v Commission

(Case T-5/23)  (1)

(Competition - Concentrations - Pharmaceutical industry market - Genetic sequencing systems - Acquisition by Illumina of sole control over Grail - Decision imposing interim measures pursuant to Article 8(5)(c) of Regulation (EC) No 139/2004 - Withdrawal of the contested act - Disappearance of the subject matter of the action - No need to adjudicate)

(C/2025/1884)

Language of the case: English

Parties

Applicant: Illumina, Inc. (Wilmington, Delaware, United States) (represented by: D. Beard, Barrister-at-Law, and by F. González Díaz, M. Siragusa and T. Spolidoro, lawyers)

Defendant: European Commission (represented by: G. Conte, B. Ernst and P. Berghe, acting as Agents)

Re:

By its action based on Article 263 TFEU, the applicant seeks the annulment of Commission Decision C(2022) 7889 final of 28 October 2022 to adopt interim measures (Case M.10938 – Illumina/Grail) pursuant to Article 8(5)(c) of Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings (OJ 2004 L 24, p. 1).

Operative part of the order

1.

There is no longer any need to adjudicate on the action.

2.

There is no longer any need to adjudicate on the application to intervene lodged by Grail LLC.

3.

The European Commission shall bear its own costs and shall pay those incurred by Illumina, Inc.

4.

Grail LLC shall bear its own costs.


(1)   OJ C 63, 20.2.2023.


ELI: http://data.europa.eu/eli/C/2025/1884/oj

ISSN 1977-091X (electronic edition)


Top